Correlation Between Spyre Therapeutics and Oshidori International

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Oshidori International at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Oshidori International into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Oshidori International Holdings, you can compare the effects of market volatilities on Spyre Therapeutics and Oshidori International and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Oshidori International. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Oshidori International.

Diversification Opportunities for Spyre Therapeutics and Oshidori International

-0.72

Correlation Coefficient

Spyre Therapeutics  Oshidori International

Pay attention - limited upside

The 3 months correlation between Spyre and Oshidori is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Oshidori International Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oshidori International and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Oshidori International. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oshidori International has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Oshidori International go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Oshidori International

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Oshidori International. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 16.31 times less risky than Oshidori International. The stock trades about -0.12 of its potential returns per unit of risk. The Oshidori International Holdings is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  1.00  in Oshidori International Holdings on October 8, 2024 and sell it today you would earn a total of  2.60  from holding Oshidori International Holdings or generate 260.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  Oshidori International Holding

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Oshidori International

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Oshidori International Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady fundamental indicators, Oshidori International reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Spyre Therapeutics and Oshidori International

The main advantage of trading using opposite Spyre Therapeutics and Oshidori International positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Oshidori International can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oshidori International will offset losses from the drop in Oshidori International's long position.

The idea behind Spyre Therapeutics and Oshidori International Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.